Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,132 public trials 395 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects

NCT00432510

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • University of California, San Diego San Diego, California, United States
  • Allergy and Asthma Clinical Research, Inc. Walnut Creek, California, United States
  • Family Allergy and Asthma Center Atlanta, Georgia, United States
  • Institute for Asthma and Allergy Wheaton, Maryland, United States
View Trial Details
Completed

Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)

NCT02865720

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Toyohashi Municipal Hospital Toyohashi, Aiti, Japan
  • Asahi General Hospital Asahi, Chiba, Japan
  • Gunma University Hospital Maebashi, Gunma, Japan
  • Kobe University Hospital Kobe, Hyōgo, Japan
View Trial Details
Completed

Peer-Educator-coordinated vs Nurse-coordinated ART Refill for Adolescents and Young Adults Living With HIV in Lesotho

NCT03969030

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Boiketsiso HC Butha-Buthe, Lesotho
  • Linakeng HC Butha-Buthe, Lesotho
  • Makhunoane HC Butha-Buthe, Lesotho
  • Motete HC Butha-Buthe, Lesotho
View all 20 locations
View Trial Details
Completed

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

NCT02586805

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • UC San Diego School of Medicine San Diego, California, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
View all 41 locations
View Trial Details
Completed

A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants

NCT02093923

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • UC San Diego Health System - La Jolla San Diego, California, United States
  • Allergy & Asthma Clinical Research Walnut Creek, California, United States
  • University of South Florida Asthma, Allergy or Immunology Clinical Research Unit Tampa, Florida, United States
  • Institute for Asthma & Allergy, PC Chevy Chase, Maryland, United States
View all 14 locations
View Trial Details
Completed

Gammagard Liquid and rHuPH20 in PID

NCT00814320

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Cypress, California, United States
  • Irvine, California, United States
  • Los Angeles, California, United States
  • San Francisco, California, United States
View all 14 locations
View Trial Details
Completed

Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects

NCT00546871

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Los Angeles, California, United States
  • Centennial, Colorado, United States
  • North Palm Beach, Florida, United States
  • Atlanta, Georgia, United States
View Trial Details
Completed

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

NCT01485796

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • University of California, Irvine Irvine, California, United States
  • IMMUNOe International Research Centers Thornton, Colorado, United States
  • Allergy Associates of the Palm Beaches, PA North Palm Beach, Florida, United States
  • LSU Health Sciences Center & Children´s Hospital New Orleans, Louisiana, United States
View Trial Details

Related conditions